ArticleOrphanet journal of rare diseases2019

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.

Elisabetta Buscarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.